Liminal Biosciences Inc (DELISTED) (LMNL:DL)
8.50
0.00 (0.00%)
USD |
NASDAQ |
Sep 26, 16:00
Liminal Biosciences Revenue (TTM): 0.3635M for June 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.3635M |
| March 31, 2023 | 0.4031M |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 0.5098M |
| September 30, 2021 | 0.5389M |
| June 30, 2021 | 0.5555M |
| March 31, 2021 | 0.5611M |
| December 31, 2020 | 0.5461M |
| September 30, 2020 | -2.027M |
| June 30, 2020 | -1.552M |
| March 31, 2020 | -1.008M |
| December 31, 2019 | 0.5433M |
| September 30, 2019 | -6.285M |
| June 30, 2019 | 2.519M |
| March 31, 2019 | 17.57M |
| December 31, 2018 | 19.26M |
| September 30, 2018 | 20.42M |
| June 30, 2018 | 30.17M |
| March 31, 2018 | 17.24M |
| December 31, 2017 | 17.51M |
| September 30, 2017 | 28.62M |
| June 30, 2017 | 12.31M |
| Date | Value |
|---|---|
| March 31, 2017 | 12.18M |
| December 31, 2016 | 12.33M |
| September 30, 2016 | 19.78M |
| June 30, 2016 | 21.24M |
| March 31, 2016 | 21.04M |
| December 31, 2015 | 18.76M |
| September 30, 2015 | 17.50M |
| June 30, 2015 | 15.30M |
| March 31, 2015 | 16.99M |
| December 31, 2014 | 20.65M |
| September 30, 2014 | 16.21M |
| June 30, 2014 | 19.82M |
| March 31, 2014 | 20.82M |
| December 31, 2013 | 20.03M |
| September 30, 2013 | 23.59M |
| June 30, 2013 | 25.55M |
| March 31, 2013 | 26.71M |
| December 31, 2012 | 23.36M |
| September 30, 2012 | 23.19M |
| June 30, 2012 | 18.90M |
| March 31, 2012 | 15.81M |
| December 31, 2011 | 17.61M |
| September 30, 2011 | 10.48M |
| June 30, 2011 | 9.060M |
| March 31, 2011 | 11.05M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
-6.285M
Minimum
Sep 2019
2.519M
Maximum
Jun 2019
-0.3332M
Average
0.5098M
Median
Dec 2021
Revenue (TTM) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 175.51M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.386M |
| Xenon Pharmaceuticals Inc | -- |